-
公开(公告)号：US20230089374A1
公开(公告)日：2023-03-23
申请号：US17751144
申请日：2022-05-23
Applicant: BIOMARIN PHARMACEUTICAL INC.
IPC: C07D249/04 , C07D401/12 , C07D401/14 , C07D403/12 , C07D405/12 , C07D409/12 , C07D417/12
Abstract: Described herein are compounds, methods of making such compounds, pharmaceutical compositions and medicaments containing such compounds, and methods of using such compounds to treat or prevent diseases or disorders associated with the enzyme glycolate oxidase (GO). Such diseases or disorders include, for example, disorders of glyoxylate metabolism, including primary hyperoxaluria, that are associated with production of excessive amounts of oxalate.
-
公开(公告)号：US20230079913A1
公开(公告)日：2023-03-16
申请号：US17751136
申请日：2022-05-23
Applicant: BIOMARIN PHARMACEUTICAL INC.
IPC: C07D249/04 , C07D401/12 , C07D401/14 , C07D403/12 , C07D405/12 , C07D409/12 , C07D417/12
Abstract: Described herein are compounds, methods of making such compounds, pharmaceutical compositions and medicaments containing such compounds, and methods of using such compounds to treat or prevent diseases or disorders associated with the enzyme glycolate oxidase (GO). Such diseases or disorders include, for example, disorders of glyoxylate metabolism, including primary hyperoxaluria, that are associated with production of excessive amounts of oxalate.
-
Search Results
2
records
(took 0.011 seconds)
